Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule in Healthy Japanese Male Subjects
NCT02171000
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
BIBR 1048 MS
Sponsor
Boehringer Ingelheim